Literature DB >> 18581753

Understanding the inflammatory response to cardiac surgery.

J McGuinness1, D Bouchier-Hayes, J M Redmond.   

Abstract

The systemic inflammatory response to cardiac surgery is common, and resultant impairment of multiple organ function is generally mild or subclinical due to physiological reserve within organ systems. Unfortunately, the changing profile of patients referred for surgery suggests that the systemic inflammatory response may prominently influence surgical outcome in the future. Older, co-morbid patients with more limited physiological reserve are being referred for complex lengthy procedures, and paediatric surgery has witnessed a shift to earlier complex primary correction or palliation involving long cardiopulmonary bypass times or a period of suboptimal organ perfusion using circulatory arrest or low flow cardiopulmonary bypass. Unique to cardiac surgery is the predictability of the inflammatory response, but prophylactic therapies have not translated into clinical benefit, which the preconditioning phenomenon may address.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18581753     DOI: 10.1016/s1479-666x(08)80113-8

Source DB:  PubMed          Journal:  Surgeon        ISSN: 1479-666X            Impact factor:   2.392


  18 in total

Review 1.  Preconditioning and its clinical potential.

Authors:  P Magill; T Murphy; D J Bouchier-Hayes; K J Mulhall
Journal:  Ir J Med Sci       Date:  2009-03-21       Impact factor: 1.568

2.  Preoperative statin therapy in cardiac surgery is more effective in patients who display preoperative activation of the inflammatory system.

Authors:  José Martínez-Comendador; José Rubio Alvarez; Juan Sierra; Elvis Teijeira; Belén Adrio
Journal:  Tex Heart Inst J       Date:  2013

Review 3.  The use of CD47-modified biomaterials to mitigate the immune response.

Authors:  Jillian E Tengood; Robert J Levy; Stanley J Stachelek
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-10

4.  The impact of high-dose statin therapy on transendothelial neutrophil migration and serum cholesterol levels in healthy male volunteers.

Authors:  Aisling Kinsella; Adnan Raza; Susan Kennedy; Yue Fan; Alfred E Wood; R W Watson
Journal:  Eur J Clin Pharmacol       Date:  2011-06-08       Impact factor: 2.953

Review 5.  Influence of cirrhosis in cardiac surgery outcomes.

Authors:  Juan C Lopez-Delgado; Francisco Esteve; Casimiro Javierre; Josep L Ventura; Rafael Mañez; Elisabet Farrero; Herminia Torrado; David Rodríguez-Castro; Maria L Carrio
Journal:  World J Hepatol       Date:  2015-04-18

Review 6.  Outcomes of abdominal surgery in patients with liver cirrhosis.

Authors:  Juan C Lopez-Delgado; Josep Ballus; Francisco Esteve; Nelson L Betancur-Zambrano; Vicente Corral-Velez; Rafael Mañez; Antoni J Betbese; Joan A Roncal; Casimiro Javierre
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

7.  Association of metabolic equivalent of task (MET) score in length of stay in hospital following radical cystectomy with urinary diversion: a multi-institutional study.

Authors:  Chun Shea; Abdul Rouf Khawaja; Khalid Sofi; Ghulam Nabi
Journal:  Int Urol Nephrol       Date:  2021-03-06       Impact factor: 2.370

8.  Microcirculation and macrocirculation in cardiac surgical patients.

Authors:  Elli-Sophia Tripodaki; Athanasios Tasoulis; Antigoni Koliopoulou; Ioannis Vasileiadis; Leonidas Vastardis; Giorgos Giannis; Mihalis Argiriou; Christos Charitos; Serafim Nanas
Journal:  Crit Care Res Pract       Date:  2012-06-05

9.  Oxidant Status following Cardiac Surgery with Phosphorylcholine-Coated Extracorporeal Circulation Systems.

Authors:  Ali Can Hatemi; Kadir Çeviker; Aybala Tongut; İlhan Özgöl; Murat Mert; Ayşem Kaya
Journal:  Oxid Med Cell Longev       Date:  2016-11-23       Impact factor: 6.543

10.  RECCAS - REmoval of Cytokines during CArdiac Surgery: study protocol for a randomised controlled trial.

Authors:  Andreas Baumann; Dirk Buchwald; Thorsten Annecke; Martin Hellmich; Peter K Zahn; Andreas Hohn
Journal:  Trials       Date:  2016-03-12       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.